Materias dentro de su búsqueda.
Mostrando 4,281 - 4,300 Resultados de 4,918 Para Buscar '"Pfizer"', tiempo de consulta: 0.21s Limitar resultados
  1. 4281
    “…In the 10 patients who had atrial fibrillation prior to ibrutinib, all 10  were on beta blockers, one was on diltiazem, three were on amiodarone, one was on flecainide, one was on digoxin, and one was on Tikosyn® (Pfizer, Inc., New York, NY). The ibrutinib dose was decreased/discontinued in two patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Management of Atrial Fibrillation in Patients on Ibrutinib: A Cleveland Clinic Experience
  2. 4282
    “…MacGowan, Merck: Commercial grant, Research support; Paratek: Commercial grant, Research support; VenatoRx: Commercial grant, Research support; Bayer: Commercial grant, Research support; Achaogen: Commercial grant, Research support; AiCuris: Collaborator and Commercial grant, Grant recipient and Research support; Polyphor: Commercial grant, Research support; Pfizer: Commercial grant, Research support; Roche: Commercial grant, Research support; Melinta: Industrial partner, Research support; MedImmune (AZ): Industrial partner (IMI), Research support; NIHR England: Grant Investigator, Grant recipient; MRC (UK): Grant Investigator, Grant recipient; Innovate UK: Grant Investigator, Grant recipient. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1387. Phase I Study to Evaluate the Safety and Pharmacokinetics (PK) of Single and Multiple Ascending Doses (SAD/MAD) of Intravenous (IV) Minocycline in Healthy Adult Subjects
  3. 4283
    “…Rebiotix: Medical Officer and Scientific Advisor, Consulting fee. Pfizer: Consultant, Consulting fee. MGB Pharma: Consultant, Consulting fee. sanofi pasteur: Consultant, Consulting fee. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    976. Clostridium difficile Colonization Molecular Epidemiology and Anti-toxin Serological Responses in Healthy Infants: A Prospective Cohort Study
  4. 4284
    “…Astellas: Grant Investigator and Investigator, Grant recipient and Research grant. Pfizer: Grant Investigator, Research support. Gilead: Consultant and Scientific Advisor, Consulting fee. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1396. Predictions of Isavuconazonium Sulfate Dosage in Patients Aged 6 Months: <18 Years by Physiologically Based Pharmacokinetic Modeling
  5. 4285
    “…[Image: see text] DISCLOSURES: F. Martinon-Torres, Pfizer: Consultant, Consulting fee. SPMSD: Consultant, Consulting fee. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005
  6. 4286
    “…Kontoyiannis, Merck: Consultant, Research support and Speaker honorarium. Pfizer: Consultant, Research support. Astellas: Consultant, Research support and Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    380. Drosophila melanogaster as a Facile Model for Large-Scale Studies of Virulence Mechanisms and Antifungal Drug Efficacy in Candida auris Candidiasis
  7. 4287
    “…Patel, Merck: Grant Investigator, Grant recipient and Research grant. Pfizer: Grant Investigator, Research grant.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2321. Epidemiology of Staphylococcus aureus Infections in Patients Admitted to Freestanding Pediatric Hospitals, 2009–2016
  8. 4288
    “…Kontoyiannis, Merck: Consultant, Research support and Speaker honorarium; Pfizer: Consultant, Research support; Astellas: Consultant, Research support and Speaker honorarium; Gilead: Speaker’s Bureau, Speaker honorarium; F2G Inc: Speaker’s Bureau, Speaker honorarium; Cidara Inc.: Speaker’s Bureau, Speaker honorarium; Jazz Pharmaceuticals: Speaker’s Bureau, Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2100. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective in Eradicating Candida auris Biofilms
  9. 4289
    “…Janssen: Grant Investigator and Scientific Advisor, Consulting fee, Grant recipient and Speaker honorarium. Pfizer: Consultant, Consulting fee and Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2337. Clinical Characteristics of Children Infected With Macrolide-Resistant Mycoplasma Pneumonia in Central Ohio—Preliminary Data
  10. 4290
    “…Janssen Pharmacueticals: Investigator, Grant recipient. Pfizer: Consultant, Research grant. Novavax: Consultant, none. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    733. Incidence and Evaluation of the Change in Functional Status Associated with Respiratory Syncytial Virus Infection in Hospitalized Older Adults
  11. 4291
    “…Anderson, NovaVax: Grant Investigator, Research grant. Pfizer: Grant Investigator, Research grant. AbbVie: Consultant, Consulting fee. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    354. Evidence of Aspergillosis Among Patients With Influenza-Associated Hospitalizations—United States, 2005–2017
  12. 4292
    por Downes, Kevin, Zuppa, Athena
    Publicado 2018
    “….: Investigator, Research support. Pfizer, Inc.: Investigator, Research support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1402. Cystatin C Improves Estimation of Vancomycin Clearance in Critically Ill Children Using a Population Pharmacokinetic Modeling Approach
  13. 4293
    “…Kontoyiannis, Merck: Consultant, Research support and Speaker honorarium. Pfizer: Consultant, Research support. Astellas: Consultant, Research support and Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    355. Invasive Pulmonary Aspergillosis (IPA) Complicating Respiratory Viral Infections in Patients With Hematological Malignancies
  14. 4294
    “…GSK: Investigator, Research grant. Pfizer: Investigator, Research support. Protein Science: Investigator, Research grant. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2275. Parental Risk Factors for Fever in their Children 7–10 Days After the First Dose of Measles-Containing Vaccines
  15. 4295
    “…S.M. reports research grants, consulting and speaker’s fees from GSK, BMS/Pfizer, Sanquin, Aspen, Bayer and Daiichi Sankyo. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ESHRE guideline: recurrent pregnancy loss
  16. 4296
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
  17. 4297
    “…[Image: see text] DISCLOSURES: Octavio Ramilo, MD, Bill & Melinda Gates Foundation: Research Grant; Janssen: Research Grant; Merck: Advisory Board; NIH: Research Grant; Ohio Children’s Hospital Association (OCHA): Research Grant; Pfizer: Advisory Board, Consultant, Lectures; Sanofi/Medimmune: Advisory Board.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
  18. 4298
    “…Downes, MD, Merck: Grant/Research Support, Research Grant; Pfizer: Grant/Research Support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1335. A Translational Nephrotoxicity Model to Probe Acute Kidney Injury with Vancomycin and Piperacillin–Tazobactam
  19. 4299
    “…Downes, MD, Merck: Grant/Research Support, Research Grant; Pfizer: Grant/Research Support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1744. CMV Infection and Management Among Pediatric Solid-Organ Transplant Recipients
  20. 4300
    “…The main funding institutions were the National Institutes of Health (United States), Hoffmann-La Roche (Switzerland), Pfizer (United States), Merck Sharp & Dohme (United States) and Novartis (Switzerland). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis
Herramientas de búsqueda: RSS